Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Ad-MAGEA3 |
Synonyms | |
Therapy Description |
Ad-MAGEA3 is a cancer vaccine comprising a replication-defective adenovirus engineered to express MAGE-A3, which may result in enhanced immune response against MAGE-A3 expressing tumors (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Ad-MAGEA3 | Adenovirus MAGE-A3|AdMA3|MAGE-A3-expressing Adenovirus Type 5 Vaccine | Ad-MAGEA3 is a cancer vaccine comprising a replication-defective adenovirus engineered to express MAGE-A3, which may result in enhanced immune response against MAGE-A3 expressing tumors (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|